POLITECNICO DI BARI - Catalogo dei prodotti della Ricerca

Zaccaria, Gian Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.503
EU - Europa 2.171
AS - Asia 1.474
SA - Sud America 456
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 39
OC - Oceania 1
Totale 6.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.427
RU - Federazione Russa 1.403
SG - Singapore 484
BR - Brasile 380
IT - Italia 350
CN - Cina 310
VN - Vietnam 200
HK - Hong Kong 127
KR - Corea 82
BD - Bangladesh 75
FR - Francia 71
JP - Giappone 62
DE - Germania 58
FI - Finlandia 46
GB - Regno Unito 42
SE - Svezia 42
NL - Olanda 38
CA - Canada 36
IE - Irlanda 30
AR - Argentina 26
IN - India 23
AT - Austria 22
MX - Messico 19
PL - Polonia 19
ES - Italia 17
TR - Turchia 17
EC - Ecuador 15
IQ - Iraq 15
ZA - Sudafrica 13
ID - Indonesia 12
CO - Colombia 9
UZ - Uzbekistan 8
CL - Cile 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
JO - Giordania 6
PE - Perù 6
PK - Pakistan 6
AZ - Azerbaigian 5
LT - Lituania 5
MA - Marocco 5
UA - Ucraina 5
VE - Venezuela 5
AM - Armenia 4
GE - Georgia 4
GR - Grecia 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
BZ - Belize 3
CR - Costa Rica 3
DZ - Algeria 3
LB - Libano 3
PY - Paraguay 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
DK - Danimarca 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.645
Salva come PNG Salva come JPEG
Città #
Dallas 1.111
Moscow 315
Singapore 283
Council Bluffs 138
Ashburn 131
Hong Kong 122
San Jose 119
The Dalles 99
Rome 95
New York 92
Hefei 83
Seoul 82
Ho Chi Minh City 66
Tokyo 59
Santa Clara 58
Lauterbourg 52
Boardman 50
Hanoi 50
Los Angeles 43
Bari 40
Kent 39
Helsinki 35
São Paulo 33
Conversano 32
Dublin 30
Amsterdam 29
Beijing 26
West Jordan 20
Frankfurt am Main 18
Ogden 17
Warsaw 17
Denver 15
Orem 15
Poplar 15
Rio de Janeiro 15
Washington 15
Milan 14
Phoenix 14
Vienna 13
Düsseldorf 12
Montreal 12
Johannesburg 11
Brooklyn 10
Chicago 10
Munich 10
Chennai 9
Da Nang 9
Houston 9
Porto Alegre 9
Atlanta 8
Boston 8
Nuremberg 8
Toronto 8
Zola Predosa 8
Campinas 7
Fasano 7
Lappeenranta 7
Mexico City 7
Tashkent 7
Amman 6
Assago 6
Belo Horizonte 6
Brasília 6
Chandler 6
Hillsboro 6
London 6
Molfetta 6
Quito 6
San Francisco 6
Turin 6
Ankara 5
Baku 5
Biên Hòa 5
Catania 5
Caxias do Sul 5
Haiphong 5
Miami 5
Ninh Bình 5
Osasco 5
Philadelphia 5
Athens 4
Baghdad 4
Can Tho 4
Curitiba 4
Dubai 4
Guangzhou 4
Hải Dương 4
Lima 4
Manchester 4
Nairobi 4
Naples 4
Portsmouth 4
Ribeirão Preto 4
Santo André 4
Stockholm 4
Tbilisi 4
Thái Bình 4
Turku 4
Buenos Aires 3
Bắc Ninh 3
Totale 3.870
Salva come PNG Salva come JPEG
Nome #
Highly reliable personalized noninvasive hemoglobin estimation by using Vision Transformers and dual fine-tuning 835
A multimodal framework for assessing the link between pathomics, transcriptomics, and pancreatic cancer mutations 215
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 180
Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs 178
A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PROGNOSTICATORS IN MANTLE CELL LYMPHOMA: RESULTS FROM THE MCL0208 TRIAL FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) 177
Development and validation of a machine learning prognostic model based on an epigenomic signature in patients with pancreatic ductal adenocarcinoma 173
A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants 169
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial 165
Primary, bilateral and diffuse renal non‐hodgkin’s lymphoma in a young woman suffering from turner syndrome 164
Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification 164
Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients 164
A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma 162
The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 155
ARGO 2.0: a Hybrid NLP/ML Framework for Diagnosis Standardization 154
A time-dependent explainable radiomic analysis from the multi-omic cohort of CPTAC-Pancreatic Ductal Adenocarcinoma 151
Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset 151
IgM-Gammopathies Transformed into Aggressive Lymphoma: Incidence, Basal Clinical Features and Outcome of a Registry Based, Spanish Retrospective Series 147
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma 145
Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial 142
P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL 140
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology 132
A new ensemble method for detecting anomalies in gene expression matrices 132
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival 130
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma 127
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer 123
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data 117
An Approach Based on Process Modeling for Implementing a Health Information Technology in Clinical Practice 116
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes 114
Data quality improvement of a multicenter clinical trial dataset 113
Development and validation of a simplified score to predict early relapse in newly diagnosed multiple myeloma in a pooled dataset of 2,190 patients 110
Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study) 110
Unraveling MRD Dynamics to Enhance Outcome Prediction in Mantle Cell Lymphoma—Insights from the Fondazione Italiana Linfomi MCL0208 Clinical Trial 109
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes 102
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial 95
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 94
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network 92
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 89
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 86
Multimodal framework for TACE treatment response prediction in patients with hepatocellular carcinoma 86
Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 83
ZebraBeat : A flexible platform for the analysis of the cardiac rate in zebrafish embryos 83
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 81
Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari 80
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML 79
Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL) 75
Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma 71
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy 49
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial 37
Pharmacokinetic-pharmacodynamic modeling of tumor angiogenesis unveils the need for time-adjustable drug regimens 36
Development and independent validation of explainable radiomics-based machine learning models for prognosis in colorectal liver metastases 28
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study 11
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)‐MCL0208 clinical trial 8
Totale 6.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 1 3
2022/2023145 1 0 0 2 1 3 0 2 11 107 15 3
2023/2024406 32 17 18 10 104 98 5 0 29 34 1 58
2024/20251.021 19 6 91 8 52 27 58 66 192 160 240 102
2025/20265.051 115 503 1.047 569 255 448 918 563 126 170 181 156
2026/2027102 55 47 0 0 0 0 0 0 0 0 0 0
Totale 6.729